STRATEC SE (SBS.DE) Stock Price, Forecast & Analysis
Europe - FRA:SBS - DE000STRA555 - Common Stock
SBS.DE Key Statistics, Chart & Performance
The current stock price of SBS.DE is 19.94 EUR. In the past month the price decreased by -31.74%. In the past year, price decreased by -35.27%.
SBS.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 16.28 | 100.05B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.57 | 49.86B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.86 | 23.38B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.96 | 23.51B | ||
| BIM.PA | BIOMERIEUX | 27.62 | 12.62B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.68 | 3.77B | ||
| DIA.MI | DIASORIN SPA | 17.14 | 3.33B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.44 | 1.26B | ||
| DRW8.DE | DRAEGERWERK AG | 9.02 | 1.09B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.74 | 1.00B | ||
| ELN.MI | EL.EN. SPA | 17.02 | 873.70M | ||
| GVS.MI | GVS SPA | 46.67 | 794.56M |
Related stock screener links
About SBS.DE
Company Profile
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,416 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Company Info
STRATEC SE
Gewerbestr. 37
BIRKENFELD BADEN-WUERTTEMBERG DE
Employees: 1416
Phone: 49708279160
STRATEC SE / SBS.DE FAQ
Can you describe the business of STRATEC SE?
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,416 full-time employees. The firm is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. The company also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
What is the stock price of STRATEC SE today?
The current stock price of SBS.DE is 19.94 EUR. The price decreased by -3.44% in the last trading session.
What is the dividend status of STRATEC SE?
STRATEC SE (SBS.DE) has a dividend yield of 2.65%. The yearly dividend amount is currently 0.55.
What is the ChartMill technical and fundamental rating of SBS stock?
SBS.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for SBS.DE stock?
13 analysts have analysed SBS.DE and the average price target is 37.16 EUR. This implies a price increase of 86.37% is expected in the next year compared to the current price of 19.94.
Can you provide the PE ratio for SBS stock?
The PE ratio for STRATEC SE (SBS.DE) is 15.11. This is based on the reported non-GAAP earnings per share of 1.32 and the current share price of 19.94 EUR.
Is STRATEC SE (SBS.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SBS.DE.
SBS.DE Technical Analysis
SBS.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SBS.DE. Both the profitability and the financial health of SBS.DE get a neutral evaluation. Nothing too spectacular is happening here.
SBS.DE Financial Highlights
Over the last trailing twelve months SBS.DE reported a non-GAAP Earnings per Share(EPS) of 1.32. The EPS increased by 4.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.22% | ||
| ROA | 3.79% | ||
| ROE | 6.77% | ||
| Debt/Equity | 0.4 |
SBS.DE Forecast & Estimates
13 analysts have analysed SBS.DE and the average price target is 37.16 EUR. This implies a price increase of 86.37% is expected in the next year compared to the current price of 19.94.
For the next year, analysts expect an EPS growth of -4.02% and a revenue growth 3.97% for SBS.DE